TH.TO

Theratechnologies Inc. [TH.TO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

TH.TO Stock Summary

Top 10 Correlated ETFs

TH.TO


Top 10 Correlated Stocks

TH.TO


In the News

TH.TO Financial details

Company Rating
Neutral
Market Cap
52.52M
Income
-29.13M
Revenue
79.73M
Book val./share
-1.72
Cash/share
0.95
Dividend
-
Dividend %
-
Employees
144
Optionable
No
Shortable
Yes
Earnings
26 Feb 2024
P/E
-1.33
Forward P/E
-3.74
PEG
2.84
P/S
0.48
P/B
-0.93
P/C
2.28
P/FCF
-3.81
Quick Ratio
0.33
Current Ratio
0.42
Debt / Equity
-1.4
LT Debt / Equity
-0.02
-
-
EPS (TTM)
-0.32
EPS next Y
-0.58
EPS next Q
-0.12
EPS this Y
47.06%
EPS next Y
78.96%
EPS next 5Y
78.96%
EPS last 5Y
53.02%
Revenue last 5Y
12.67%
Revenue Q/Q
18.84%
EPS Q/Q
-69.2%
-
-
-
-
SMA20
35.8%
SMA50
-21.71%
SMA100
-51.75%
Inst Own
0%
Inst Trans
0%
ROA
-51%
ROE
84%
ROC
0.46%
Gross Margin
74%
Oper. Margin
-24%
Profit Margin
-37%
Payout
-
Shs Outstand
24.2M
Shs Float
14.52M
-
-
-
-
Target Price
-
52W Range
1.22-6.48
52W High
-63.83%
52W Low
+117%
RSI
54.1
Rel Volume
0.25
Avg Volume
84.46K
Volume
21.4K
Perf Week
-3.56%
Perf Month
61.94%
Perf Quarter
-56.94%
Perf Half Y
-57.95%
-
-
-
-
Beta
1.606
-
-
Volatility
0.05%, 0.31%
Prev Close
0.93%
Price
2.17
Change
0.46%

TH.TO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-11-30

Metric History 2018-11-302019-11-302020-11-302021-11-30 2022-11-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.580.820.860.760.84
Net income per share
-0.06-0.23-0.29-0.34-0.5
Operating cash flow per share
0-0.04-0.18-0.16-0.15
Free cash flow per share
0-0.09-0.18-0.16-0.16
Cash per share
0.640.530.270.440.35
Book value per share
0.460.320.040.19-0.24
Tangible book value per share
0.26-0.19-0.37-0.07-0.39
Share holders equity per share
0.460.320.040.19-0.24
Interest debt per share
0.680.990.790.680.77
Market cap
1.88B940.77M713.8M1.21B830.84M
Enterprise value
1.89B962.85M756.45M1.25B873.69M
P/E ratio
-414.34-53.8-31.49-38.26-17.59
Price to sales ratio
42.5514.8810.8117.3810.38
POCF ratio
-5.61K-277.43-52.66-83.85-56.55
PFCF ratio
-5.02K-134.15-52.54-82.89-53
P/B Ratio
53.5337.88221.468.35-36.81
PTB ratio
53.5337.88221.468.35-36.81
EV to sales
42.7815.2311.4517.910.91
Enterprise value over EBITDA
1.87K24.07K-82.42-76.59-32.17
EV to operating cash flow
-5.64K-283.94-55.81-86.36-59.47
EV to free cash flow
-5.05K-137.3-55.68-85.38-55.73
Earnings yield
0-0.02-0.03-0.03-0.06
Free cash flow yield
0-0.01-0.02-0.01-0.02
Debt to equity
1.412.8717.183.2-2.96
Debt to assets
0.440.610.550.480.72
Net debt to EBITDA
10.16552-4.65-2.23-1.58
Current ratio
2.742.051.552.040.64
Interest coverage
-1.38-1.49-3.35-4.46-6.14
Income quality
0.070.270.60.460.31
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.130.130.190.210.22
Research and developement to revenue
0.180.170.270.40.46
Intangibles to total assets
0.140.340.320.20.16
Capex to operating cash flow
0.121.0700.010.07
Capex to revenue
0-0.0600-0.01
Capex to depreciation
-0.01-0.480-0.02-0.08
Stock based compensation to revenue
0.020.020.020.030.05
Graham number
0.791.280.531.221.63
ROIC
-0.03-0.11-0.29-0.33-0.87
Return on tangible assets
-0.05-0.22-0.33-0.33-0.6
Graham Net
-0.18-0.44-0.7-0.42-0.67
Working capital
46.79M39.04M22.89M46.83M-40.91M
Tangible asset value
19.92M-14.85M-28.63M-6.07M-37.58M
Net current asset value
-2.5M-16.54M-32.11M-9.54M-42.46M
Invested capital
1.412.8717.183.2-2.96
Average receivables
9.27M10.54M11.65M12.06M11.64M
Average payables
10.51M14.35M15.31M16.52M14.21M
Average inventory
9.18M16.01M23.04M27.14M24.41M
Days sales outstanding
90.7658.4172.8657.1356.28
Days payables outstanding
439.02183.45237.57243.64178.98
Days of inventory on hand
312.26292.95341.16457.29273.45
Receivables turnover
4.026.255.016.396.49
Payables turnover
0.831.991.541.52.04
Inventory turnover
1.171.251.070.81.33
ROE
-0.13-0.7-7.03-1.792.09
Capex per share
0-0.0500-0.01

Quarterly Fundamentals Overview

Last date of statement is 2023-08-31 for Q3

Metric History 2022-08-312022-11-302023-02-282023-05-31 2023-08-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.220.230.210.180.86
Net income per share
-0.08-0.08-0.11-0.1-0.03
Operating cash flow per share
-0.01-0.09-0.03-0.040.22
Free cash flow per share
-0.02-0.09-0.04-0.040.22
Cash per share
0.380.350.30.260.95
Book value per share
-0.19-0.24-0.33-0.43-1.72
Tangible book value per share
-0.19-0.4-0.33-0.43-1.72
Share holders equity per share
-0.19-0.24-0.33-0.43-1.72
Interest debt per share
0.710.720.710.712.52
Market cap
842.01M829.77M367.54M345.58M22.11M
Enterprise value
885.03M872.63M413.5M395.3M65.38M
P/E ratio
-27.88-26.16-8.8-8.63-7.41
Price to sales ratio
40.4638.7418.4619.691.06
POCF ratio
-704.02-100.65-110.07-97.024.15
PFCF ratio
-464.94-100.4-103.21-94.864.16
P/B Ratio
-46.62-36.76-11.37-8.32-0.53
PTB ratio
-46.62-36.76-11.37-8.32-0.53
EV to sales
42.5340.7420.7722.533.14
Enterprise value over EBITDA
-192.06-189.45-97.04-58.0660.32
EV to operating cash flow
-739.99-105.85-123.84-110.9812.27
EV to free cash flow
-488.7-105.58-116.12-108.5112.3
Earnings yield
-0.01-0.01-0.03-0.03-0.03
Free cash flow yield
0-0.01-0.01-0.010.24
Debt to equity
-3.68-2.96-2.04-1.61-1.4
Debt to assets
0.690.720.830.971.03
Net debt to EBITDA
-9.34-9.3-10.79-7.339.92
Current ratio
1.050.640.840.720.42
Interest coverage
-3.57-2.53-2.33-3.20.02
Income quality
0.161.040.320.36-7.14
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.20.180.220.210.18
Research and developement to revenue
0.40.440.470.590.26
Intangibles to total assets
0.130.160.180.20.23
Capex to operating cash flow
0.5100.070.020
Capex to revenue
-0.030-0.0100
Capex to depreciation
-0.72-0.02-0.24-0.09-0.02
Stock based compensation to revenue
0.040.040.030.040.02
Graham number
0.580.670.911.09
ROIC
-0.11-0.13-0.16-0.310
Return on tangible assets
-0.09-0.1-0.16-0.18-0.02
Graham Net
-0.6-0.67-0.69-0.72-2.7
Working capital
3.38M-40.91M-12.01M-20.19M-57.09M
Tangible asset value
-30.91M-37.58M-46.58M-55.06M-54.56M
Net current asset value
-36.04M-42.46M-50.62M-59.14M-57.83M
Invested capital
-3.68-2.96-2.04-1.61-1.4
Average receivables
12.19M11.94M11.36M11.99M11.36M
Average payables
42.32M26.98M23.48M33.84M32.03M
Average inventory
24.06M21.41M17.4M12.14M7.94M
Days sales outstanding
49.8651.8646.9469.7639.34
Days payables outstanding
698.57196.27653.63616.1551.87
Days of inventory on hand
393.55299.87289.77167.97121.82
Receivables turnover
1.81.741.921.292.29
Payables turnover
0.130.460.140.150.16
Inventory turnover
0.230.30.310.540.74
ROE
0.420.350.320.240.02
Capex per share
-0.010000

TH.TO Frequently Asked Questions

What is Theratechnologies Inc. stock symbol ?

Theratechnologies Inc. is a CA stock , located in Montreal of Qc and trading under the symbol TH.TO

What is Theratechnologies Inc. stock quote today ?

Theratechnologies Inc. stock price is $2.17 today.

Is Theratechnologies Inc. stock public?

Yes, Theratechnologies Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap